http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013115737-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b29ba1a7f2e238a79002c95123eab8a3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c235a30090665e93e217a219e9e28f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3d35964cd8d0125fff44d1a0f0d58b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537765862e782a3ac532a6a061b8560f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_889b0378371784c4a3da58d60fb3f608
publicationDate 2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013115737-A3
titleOfInvention New pharmaceutical compositions of flurbiprofen and glucosamin
abstract The present invention relates to new pharmaceutical compositions of flurbiprofen or a pharmaceutically acceptable salt thereof and glucosamine or salts thereof. Particularly, the present invention relates to new pharmaceutical compositions for use in the treatment of pain and inflammatory symptoms associated with joint and cartilage disorders, especially with osteoarthritis and rheumatoid arthritis.
priorityDate 2012-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2460514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9852545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008008474-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009074889-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006290812-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395489

Total number of triples: 44.